Lonidamine, Hexokinase inhibitor
Be the first to review this product! Submit a review
|
(1 Publication)
MW 321.2 Da, Purity >98%. Hexokinase inhibitor (IC50 = 850 μM). Anticancer, antiparasitic and antispermatogenic activity in vivo. Blocks open CFTR Cl- channels in vitro. Orally active.
View Alternative Names
Atherosclerosis, susceptibility to, included, BXR, CHNG1, DKFZp686N23123, ER, ER-alpha, ER-beta, ERR a, ERR-alpha, ERR1 protein, ERR1_HUMAN, ER[a], ER[b], ESR, ESR B, ESR BETA, ESR1_HUMAN, ESRA, ESRL 1, ESRR A, ESTR B, Era, Erb, Erb2, Estr, Estra, Estradiol Receptor alpha, Estradiol Receptor beta, Estradiol receptor, Estrogen Receptor 1, Estrogen Receptor 2, Estrogen receptor, Estrogen receptor 1 (alpha), Estrogen receptor 2 (ER beta), Estrogen receptor 2 ER beta, Estrogen receptor alpha, Estrogen receptor beta 4, Estrogen receptor related 1, Estrogen receptor-like 1, Estrogen resistance, included, Estrogen-related receptor alpha, Estrra, GCCR, GCRST, GCR_HUMAN, GR, Glucocorticoid receptor, Grl1, HDL cholesterol, augmented response of, to hormone replacement, included, LGR 3, MGC75129, Myocardial infarction, susceptibility to, included, NR1I2_HUMAN, NR3A1, NR3A2, NR3B1, Nuclear receptor subfamily 1 group I member 2, Nuclear receptor subfamily 3 group A member 1, Nuclear receptor subfamily 3 group A member 2, Nuclear receptor subfamily 3 group B member 1, Nuclear receptor subfamily 3 group C member 1, ONR 1, OTTHUMP00000017718, OTTHUMP00000017719, OTTHUMP00000215173, OTTHUMP00000215174, OTTHUMP00000215175, Orphan nuclear receptor PAR 1, Orphan nuclear receptor PXR, PAR, PAR q, PRR, Pregnane X receptor, RNESTROR, SXR, Seven transmembrane helix receptor, Steroid and xenobiotic receptor, Steroid hormone receptor ERR1, TSH Receptor, TSHR_HUMAN, Thyroid adenoma hyperfunctioning, Thyroid carcinoma with thyrotoxicosis, Thyroid stimulating hormone receptor, isoform 2, Thyroid-stimulating hormone receptor, Thyrotropin receptor, Thyrotropin receptor I, Thyrotropin receptor I, hTSHR I, estrogen receptor related receptor alpha, glucocorticoid nuclear receptor variant 1, hERR1, hTSHR I, nr3c1, nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor), pregnane X nuclear receptor variant 2
- Chemical Structure
Lab
Chemical Structure - Lonidamine, Hexokinase inhibitor (AB142442)
2D chemical structure image of ab142442, Lonidamine, Hexokinase inhibitor
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
These receptors play critical roles in regulating diverse physiological processes. Glucocorticoid Receptor mediates metabolic and immune system functions activating or repressing target genes. Estrogen Receptor alpha controls reproductive and sexual development while ERRα relates to energy metabolism. TSH-R is vital in thyroid hormone synthesis. PXR is involved in detoxification processes. None of these receptors works in isolation; they often form complexes with co-activators or co-repressors to synergistically drive their biological roles.
Pathways
The pathways these receptors integrate into are intricate and highly regulated. Glucocorticoid Receptor is central to the hypothalamic-pituitary-adrenal (HPA) axis which influences stress responses and metabolic homeostasis. It interacts closely with the NF-κB pathway impacting immune responses. Estrogen Receptor alpha can activate the MAPK/ERK pathway influencing cell proliferation and apoptosis. TSH-R is critical in the cAMP signaling pathway impacting thyroid function and hormone production.
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Investigative ophthalmology & visual science 63:7 PubMed35930269
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com